BMS-564929 (BMS-564,929) — Research Compounds Library | RetatrutideCompare
Bicyclic hydantoin SARM developed by Bristol-Myers Squibb. Preclinical androgen-receptor selectivity for skeletal muscle vs prostate. Development discontinued.
Bicyclic hydantoin SARM developed by Bristol-Myers Squibb. Preclinical androgen-receptor selectivity for skeletal muscle vs prostate. Development discontinued.